The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.
The DCP Cancer Biomarkers Research Group administers this program.
Visit the EDRN website
The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.
10th EDRN Scientific Workshop
This year's event entitled, "Cancer Biomarkers in Precision Medicine" will include both lectures and panel debates. Please see the announcement to learn more.